Ivax Generic Taxol Launch Could Come In June After Summary Judgment

Ivax plans to launch a generic version of Bristol-Myers Squibb's Taxol (paclitaxel) without waiting for Bristol to appeal a Newark, N.J. federal court summary judgment that deems the majority of Bristol's paclitaxel patent claims invalid.